Analysts Set Trupanion, Inc. (NASDAQ:TRUP) Target Price at $44.67

Trupanion, Inc. (NASDAQ:TRUP) has been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $44.67.

A number of equities research analysts have recently issued reports on the company. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a report on Friday, August 9th. Piper Sandler boosted their price objective on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Bank of America boosted their price objective on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Northland Securities boosted their price target on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Finally, Stifel Nicolaus boosted their price target on Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $53.03 on Tuesday. The business’s 50 day moving average price is $48.76 and its two-hundred day moving average price is $38.95. The company has a market cap of $2.25 billion, a PE ratio of -165.72 and a beta of 1.69. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. Trupanion has a twelve month low of $19.69 and a twelve month high of $57.90.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same quarter in the previous year, the company posted ($0.10) earnings per share. The business’s revenue was up 14.6% on a year-over-year basis. On average, analysts predict that Trupanion will post -0.23 EPS for the current year.

Insider Buying and Selling at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the transaction, the chief executive officer now directly owns 99,984 shares in the company, valued at $4,647,256.32. The trade was a 6.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Fawwad Qureshi sold 624 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The disclosure for this sale can be found here. Insiders sold a total of 10,124 shares of company stock worth $482,981 over the last three months. Corporate insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Renaissance Technologies LLC acquired a new position in shares of Trupanion during the second quarter worth $4,739,000. Marshall Wace LLP increased its holdings in shares of Trupanion by 11.9% during the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider’s stock worth $32,181,000 after buying an additional 116,496 shares in the last quarter. Connors Investor Services Inc. increased its holdings in shares of Trupanion by 31.3% during the second quarter. Connors Investor Services Inc. now owns 113,567 shares of the financial services provider’s stock worth $3,339,000 after buying an additional 27,042 shares in the last quarter. Dalton Investments Inc. acquired a new stake in Trupanion in the second quarter valued at $1,029,000. Finally, OmniStar Financial Group Inc. acquired a new stake in Trupanion in the third quarter valued at $535,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.